IP Library › Granted Patent US 8,030,344

Granted Patent B2

US 8,030,344 · App. 12/043,450 · Granted Oct 4, 2011

Inhibitors of histone deacetylase

View Patent ↗

Loading inventors, assignments & file history…

Monitor This Case

Get email alerts when status or documents change.

Order Certified Copies

Most orders are placed with the USPTO same day — all within 24 business hours.

Order via The Patent Place →

Pre-filled with this patent's details

Quick Facts

Patent No.: US 8,030,344
App. No.: 12/043,450
Granted: Oct 4, 2011
Kind: B2

External Links

USPTO Patent Center↗ Full Patent PDF↗

Abstract

The invention relates to the inhibition of histone deacetylase. The invention provides compounds and methods for inhibiting histone deacetylase enzymatic activity. The invention also provides compositions and methods for treating cell proliferative diseases and conditions. One aspect of the invention provides compounds of formula (1): in which T, A and X are as described herein.

Claims (78)

1. A compound of formula (1):

or an N-oxide, hydrate, solvate, pharmaceutically acceptable salt, complex or prodrug thereof, or a racemic or scalemic mixture, diastereomer, enantiomer or tautomer thereof, wherein

T is NH 2 or OH;

A is arylene, which is optionally substituted; and

X is

(a) wherein

Y=N or CH,

n 2 =0 or 2-4 and

Z 2 is selected from the group consisting of R 15 —, R 15 —C(O)—, R 13 —C(S)—, R 15 —N(R 2 )—, R 15 —O—, R 15 —S—, R 15 —S(O) 1-2 , R 15 —C(O)—O—, R 15 —O—C(O)—, R 15 —C(O)—S—, R 15 —S—C(O)—, R 15 —C(O)—N(R 2 )—, R 15 —N(R 2 )—C(O)—, R 15 —C(S)—O—, R 15 —O—C(S)—, R 15 —C(S)—S—, R 15 —S—C(S)—, R 15 —C(S)—N(R 2 )—, R 15 —N(R 2 )—C(S)—, R 15 —O—C(O)—O—, R 15 —O—C(O)—S—, R 15 —S—C(O)—O—, R 15 —O—C(O)—N(R 2 )—, R 15 —N(R 2 )—C(O)—O—, R 15 —O—C(S)—O—, R 15 —O—C(S)—S—, R 15 —S—C(S)—O—, R 15 —O—C(S)—N(R 2 )—, R 15 —N(R 2 )—C(S)—O—, R 15 —S—C(O)—S—, R 15 —S—C(O)—N(R 2 )—, R 15 —N(R 2 )—C(O)—S—, R 15 —S—C(S)—S—, R 15 —N(R 2 )—C(O)—N(R 2 )—, R 15 —N(R 2 )—C(S)—N(R 2 )—, R 15 —N(R 2 )—C(S)—S—, R 15 —S—C(S)—N(R 2 )—, R 15 —NH—C(N(R 2 ))—NH—, R 15 —S(O) 0-2 —N(R 2 )—, R 15 —N(R 2 )—S(O) 0-2 — and R 15 —N(R 2 )—S(O) 0-2 —N(R 2 )—;

(b) wherein

n 3 =0-4 and

Z 3 is selected from the group consisting of R 15 —, R 15 —C(O)—, R 13 —C(S)—, R 15 —N(R 2 )—, R 15 —O—, R 15 —S—, R 15 —S(O) 1-2 , R 15 —C(O)—O—, R 15 —O—C(O)—, R 15 —C(O)—S—, R 15 —S—C(O)—, R 15 —C(O)—N(R 2 )—, R 15 —N(R 2 )—C(O)—, R 15 —C(S)—O—, R 15 —O—C(S)—, R 15 —C(S)—S—, R 15 —S—C(S)—, R 15 —C(S)—N(R 2 )—, R 15 —N(R 2 )—C(S)—, R 15 —O—C(O)—O—, R 15 —O—C(O)—S—, R 15 —S—C(O)—O—, R 15 —O—C(O)—N(R 2 )—, R 15 —N(R 2 )—C(O)—O—, R 15 —O—C(S)—O—, R 15 —O—C(S)—S—, R 15 —S—C(S)—O—, R 15 —O—C(S)—N(R 2 )—, R 15 —N(R 2 )—C(S)—O—, R 15 —S—C(O)—S—, R 15 —S—C(O)—N(R 2 )—, R 15 —N(R 2 )—C(O)—S—, R 15 —S—C(S)—S—, R 15 —N(R 2 )—C(O)—N(R 2 )—, R 15 —N(R 2 )—C(S)—N(R 2 )—, R 15 —N(R 2 )—C(S)—S—, R 15 —S—C(S)—N(R 2 )—, R 15 —NH—C(N(R 2 ))—NH—, R 15 —S(O) 0-2 —N(R 2 )—, R 15 —N(R 2 )—S(O) 0-2 — and R 15 —N(R 2 )—S(O) 0-2 —N(R 2 )—,

with the proviso that if n 3 is 2 and A is phenyl, then Z 3 is not R 15 —, R 15 —C(O)—, R 15 —N(R 2 )—, R 15 —O—, R 15 —S—, R 15 —S(O) 1-2 , R 15 —C(O)—O—, R 15 —O—C(O)—, R 15 —C(O)—N(R 2 )—, R 15 —N(R 2 )—C(O)—, R 15 —O—C(O)—N(R 2 )—, R 15 —N(R 2 )—C(O)—O—, R 15 —S(O) 2 —N(R 2 )—or R 15 —N(R 2 )—S(O) 2 —;

n 4 =0, 2, 3 or 4 and

Z 4 is selected from the group consisting of R 15 —, R 15 —C(O)—, R 13 —C(S)—, R 15 —N(R 2 )—, R 15 —O—, R 15 —S—, R 15 —S(O) 1-2 , R 15 —C(O)—O—, R 15 —O—C(O)—, R 15 —C(O)—S—, R 15 —S—C(O)—, R 15 —C(O)—N(R 2 )—, R 15 —N(R 2 )—C(O)—, R 15 —C(S)—O—, R 15 —O—C(S)—, R 15 —C(S)—S—, R 15 —S—C(S)—, R 15 —C(S)—N(R 2 )—, R 15 —N(R 2 )—C(S)—, R 15 —O—C(O)—O—, R 15 —O—C(O)—S—, R 15 —S—C(O)—O—, R 15 —O—C(O)—N(R 2 )—, R 15 —N(R 2 )—C(O)—O—, R 15 —O—C(S)—O—, R 15 —O—C(S)—S—, R 15 —S—C(S)—O—, R 15 —O—C(S)—N(R 2 )—, R 15 —N(R 2 )—C(S)—O—, R 15 —S—C(O)—S—, R 15 —S—C(O)—N(R 2 )—, R 15 —N(R 2 )—C(O)—S—, R 15 —S—C(S)—S—, R 15 —N(R 2 )—C(O)—N(R 2 )—, R 15 —N(R 2 )—C(S)—N(R 2 )—, R 15 —N(R 2 )—C(S)—S—, R 15 —S—C(S)—N(R 2 )—, R 15 —NH—C(N(R 2 ))—NH—, R 15 —S(O) 0-2 —N(R 2 )—, R 15 —N(R 2 )—S(O) 0-2 — and R 15 —N(R 2 )—S(O) 0-2 —N(R 2 )—,

with the proviso that if n 4 is 2 and A is phenyl, then Z 4 is not R 15 —, R 15 —C(O)—, R 15 —N(R 2 )—, R 15 —O—, R 15 —S—, R 15 —S(O) 1-2 , R 15 —C(O)—O—, R 15 —O—C(O)—, R 15 —C(O)—N(R 2 )—, R 15 —N(R 2 )—C(O)—, R 15 —O—C(O)—N(R 2 )—, R 15 —N(R 2 )—C(O)—O—, R 15 —S(O) 2 —N(R 2 )—or R 15 —N(R 2 )—S(O) 2 —;

(d) wherein

n 5 =1-4,

n 6 =1-4,

n 7 =1-4,

Z 5 is selected from the group consisting of R 15 —, R 15 —C(O)—, R 13 —C(S)—, R 15 —N(R 2 )—, R 15 —O—, R 15 —S—, R 15 —S(O) 1-2 , R 15 —C(O)—O—, R 15 —O—C(O)—, R 15 —C(O)—S—, R 15 —S—C(O)—, R 15 —C(O)—N(R 2 )—, R 15 —N(R 2 )—C(O)—, R 15 —C(S)—O—, R 15 —O—C(S)—, R 15 —C(S)—S—, R 15 —S—C(S)—, R 15 —C(S)—N(R 2 )—, R 15 —N(R 2 )—C(S)—, R 15 —O—C(O)—O—, R 15 —O—C(O)—S—, R 15 —S—C(O)—O—, R 15 —O—C(O)—N(R 2 )—, R 15 —N(R 2 )—C(O)—O—, R 15 —O—C(S)—O—, R 15 —O—C(S)—S—, R 15 —S—C(S)—O—, R 15 —O—C(S)—N(R 2 )—, R 15 —N(R 2 )—C(S)—O—, R 15 —S—C(O)—S—, R 15 —S—C(O)—N(R 2 )—, R 15 —N(R 2 )—C(O)—S—, R 15 —S—C(S)—S—, R 15 —N(R 2 )—C(O)—N(R 2 )—, R 15 —N(R 2 )—C(S)—N(R 2 )—, R 15 —N(R 2 )—C(S)—S—, R 15 —S—C(S)—N(R 2 )—, R 15 —NH—C(N(R 2 ))—NH—, R 15 —S(O) 0-2 —N(R 2 )—, R 15 —N(R 2 )—S(O) 0-2 — and R 15 —N(R 2 )—S(O) 0-2 —N(R 2 )—;

Z 6 is selected from the group consisting of R 15 —, R 15 —C(O)—, R 13 —C(S)—, R 15 —N(R 2 )—, R 15 —O—, R 15 —S—, R 15 —S(O) 1-2 , R 15 —C(O)—O—, R 15 —O—C(O)—, R 15 —C(O)—S—, R 15 —S—C(O)—, R 15 —C(O)—N(R 2 )—, R 15 —N(R 2 )—C(O)—, R 15 —C(S)—O—, R 15 —O—C(S)—, R 15 —C(S)—S—, R 15 —S—C(S)—, R 15 —C(S)—N(R 2 )—, R 15 —N(R 2 )—C(S)—, R 15 —O—C(O)—O—, R 15 —O—C(O)—S—, R 15 —S—C(O)—O—, R 15 —O—C(O)—N(R 2 )—, R 15 —N(R 2 )—C(O)—O—, R 15 —O—C(S)—O—, R 15 —O—C(S)—S—, R 15 —S—C(S)—O—, R 15 —O—C(S)—N(R 2 )—, R 15 —N(R 2 )—C(S)—O—, R 15 —S—C(O)—S—, R 15 —S—C(O)—N(R 2 )—, R 15 —N(R 2 )—C(O)—S—, R 15 —S—C(S)—S—, R 15 —N(R 2 )—C(O)—N(R 2 )—, R 15 —N(R 2 )—C(S)—N(R 2 )—, R 15 —N(R 2 )—C(S)—S—, R 15 —S—C(S)—N(R 2 )—, R 15 —NH—C(N(R 2 ))—NH—, R 15 —S(O) 0-2 —N(R 2 )—, R 15 —N(R 2 )—S(O) 0-2 — and R 15 —N(R 2 )—S(O) 0-2 —N(R 2 )—; and

Z 7 is selected from the group consisting of R 15 —, R 15 —C(O)—, R 13 —C(S)—, R 15 —N(R 2 )—, R 15 —O—, R 15 —S—, R 15 —S(O) 1-2 , R 15 —C(O)—O—, R 15 —O—C(O)—, R 15 —C(O)—S—, R 15 —S—C(O)—, R 15 —C(O)—N(R 2 )—, R 15 —N(R 2 )—C(O)—, R 15 —C(S)—O—, R 15 —O—C(S)—, R 15 —C(S)—S—, R 15 —S—C(S)—, R 15 —C(S)—N(R 2 )—, R 15 —N(R 2 )—C(S)—, R 15 —O—C(O)—O—, R 15 —O—C(O)—S—, R 15 —S—C(O)—O—, R 15 —O—C(O)—N(R 2 )—, R 15 —N(R 2 )—C(O)—O—, R 15 —O—C(S)—O—, R 15 —O—C(S)—S—, R 15 —S—C(S)—O—, R 15 —O—C(S)—N(R 2 )—, R 15 —N(R 2 )—C(S)—O—, R 15 —S—C(O)—S—, R 15 —S—C(O)—N(R 2 )—, R 15 —N(R 2 )—C(O)—S—, R 15 —S—C(S)—S—, R 15 —N(R 2 )—C(O)—N(R 2 )—, R 15 —N(R 2 )—C(S)—N(R 2 )—, R 15 —N(R 2 )—C(S)—S—, R 15 —S—C(S)—N(R 2 )—, R 15 —NH—C(N(R 2 ))—NH—, R 15 —S(O) 0-2 —N(R 2 )—, R 15 —N(R 2 )—S(O) 0-2 — and R 15 —N(R 2 )—S(O) 0-2 —N(R 2 )—; or

(e) wherein

Z 8 is selected from the group consisting of R 15 —, R 15 —C(O)—, R 13 —C(S)—, R 15 —N(R 2 )—, R 15 —O—, R 15 —S—, R 15 —S(O) 1-2 , R 15 —C(O)—O—, R 15 —O—C(O)—, R 15 —C(O)—S—, R 15 —S—C(O)—, R 15 —C(O)—N(R 2 )—, R 15 —N(R 2 )—C(O)—, R 15 —C(S)—O—, R 15 —O—C(S)—, R 15 —C(S)—S—, R 15 —S—C(S)—, R 15 —C(S)—N(R 2 )—, R 15 —N(R 2 )—C(S)—, R 15 —O—C(O)—O—, R 15 —O—C(O)—S—, R 15 —S—C(O)—O—, R 15 —O—C(O)—N(R 2 )—, R 15 —N(R 2 )—C(O)—O—, R 15 —O—C(S)—O—, R 15 —O—C(S)—S—, R 15 —S—C(S)—O—, R 15 —O—C(S)—N(R 2 )—, R 15 —N(R 2 )—C(S)—O—, R 15 —S—C(O)—S—, R 15 —S—C(O)—N(R 2 )—, R 15 —N(R 2 )—C(O)—S—, R 15 —S—C(S)—S—, R 15 —N(R 2 )—C(O)—N(R 2 )—, R 15 —N(R 2 )—C(S)—N(R 2 )—, R 15 —N(R 2 )—C(S)—S—, R 15 —S—C(S)—N(R 2 )—, R 15 —NH—C(N(R 2 ))—NH—, R 15 —S(O) 0-2 —N(R 2 )—, R 15 —N(R 2 )—S(O) 0-2 — and R 15 —N(R 2 )—S(O) 0-2 —N(R 2 )—,

with the proviso that if A is phenyl, then Z 8 is not R 15 —, R 15 —C(O)—, R 15 —N(R 2 )—, R 15 —O—, R 15 —S—, R 15 —S(O) 1-2 , R 15 —C(O)—O—, R 15 —O—C(O)—, R 15 —C(O)—N(R 2 )—, R 15 —N(R 2 )—C(O)—, R 15 —O—C(O)—N(R 2 )—, R 15 —N(R 2 )—C(O)—O—, R 15 —S(O) 2 —N(R 2 )— or R 15 —N(R 2 )—S(O) 2 —,

in which

each R 2 is independently selected from the group consisting of hydrogen, (C 1 -C 5 alkyl)-, Ar—(C 0 -C 4 alkyl)-, Het-(C 0 -C 4 alkyl)-, Hca-(C 0 -C 4 alkyl)-, Cak-(C 0 -C 4 alkyl)-, R 14 —CO—, R 14 —SO2—, R 14 —CO—NH— and R 14 —CO—O—, in which each alkyl is optionally substituted;

each R 5 is independently selected from the group consisting of H—, optionally substituted (C 1 -C 6 hydrocarbyl)-, Ar—(C 1 -C 6 hydrocarbyl)-, Het-(C 1 -C 6 hydrocarbyl)-, Hca-(C 0 -C 6 hydrocarbyl)- and Cak-(C 0 -C 6 hydrocarbyl)-;

each R 6 is independently selected from the group consisting of H—, substituted (C 1 -C 6 hydrocarbyl)- with the proviso that if the (C 1 -C 6 hydrocarbyl) has only one substituent, it is not halo or amino, Hca-(C 0 -C 1 or C 3 -C 6 hydrocarbyl)- and Cak-(C 0 -C 6 hydrocarbyl)-;

each R 7 is independently selected from the group consisting of H, optionally substituted (C 1 -C 6 hydrocarbyl)-, Hca-(C 0 -C 1 or C 3 -C 6 hydrocarbyl)- and Cak-(C 0 -C 6 hydrocarbyl)-;

each R 8 is independently selected from the group consisting of optionally substituted (C 1 -C 6 hydrocarbyl)-, Ar—(C 1 -C 6 hydrocarbyl)-, Het-(C 1 -C 6 hydrocarbyl)-, Hca-(C 0 -C 6 hydrocarbyl)- and Cak-(C 0 -C 6 hydrocarbyl)-, with the proviso that R 8 is not 2(morpholin-4-yl)ethyl;

each R 9 is independently selected from the group consisting of Hca-(C 0 -C 6 hydrocarbyl)- and Cak-(C 0 -C 6 hydrocarbyl)-;

each R 10 is independently selected from the group consisting of H—, Hca-(C 0 -C 6 hydrocarbyl)- and Cak-(C 0 -C 6 hydrocarbyl)-;

each R 11 is independently selected from the group consisting of H—, (C 1 -C 6 hydrocarbyl)-, Hca-(C 0 -C 6 hydrocarbyl)- and Cak-(C 0 -C 6 hydrocarbyl)-;

each R 12 is independently selected from the group consisting of optionally substituted (C 1 -C 6 hydrocarbyl)-, Ar—(C 1 -C 6 hydrocarbyl)-, Het-(C 1 -C 6 hydrocarbyl)-, Hca-(C 0 -C 6 hydrocarbyl)-, Cak-(C 0 -C 6 hydrocarbyl)-;

each R 13 is independently selected from the group consisting of H—, optionally substituted (C 1 -C 6 hydrocarbyl)-, Hca-(C 0 -C 6 hydrocarbyl)- and Cak-(C 0 -C 6 hydrocarbyl)-;

each R 14 is independently selected from the group consisting of Ar—and optionally substituted (C 1 -C 6 hydrocarbyl)-; and

each R 15 is independently selected from the group consisting of H—, optionally substituted (C 1 -C 6 hydrocarbyl)-, Ar—(C 0 -C 6 hydrocarbyl)-, Het-(C 0 -C 6 hydrocarbyl)-, Hca-(C 0 -C 6 hydrocarbyl)- and Cak-(C 0 -C 6 hydrocarbyl)-;

in which any (C 1 -C 6 hydrocarbyl)- moiety is optionally substituted, and each Ar is independently an optionally substituted aryl, each Het is independently an optionally substituted heteroaryl, each Hca is independently an optionally substituted heterocycloalkyl, and each Cak is independently an optionally substituted cycloalkyl.

2. The compound according to claim 1 , wherein T is NH 2 .

3. The compound according to claim 1 , wherein A is unsubstituted or optionally-substituted phenyl.

4. The compound according to claim 1 , wherein A is a 6-membered ring and the X— and carbonyl moieties are arranged in a 1,4-manner relative to one another on the ring.

5. The compound according to claim 1 , wherein A is unsubstituted arylene.

6. The compound according to claim 1 , wherein A is unsubstituted phenylene.

7. The compound according to claim 1 , wherein X is

wherein

n 2 =0 or 2-4 and

8. The compound according to claim 1 , wherein X is

wherein

n 3 =0-4 and

Z 3 is selected from the group consisting of R 15 —, R 15 —C(O)—, R 13 —C(S)—, R 15 —N(R 2 )—, R 15 —S—, R 15 —S(O) 1-2 , R 15 —C(O)—O—, R 15 —O—C(O)—, R 15 —C(O)—S—, R 15 —S—C(O)—, R 15 —C(O)—N(R 2 )—, R 15 —N(R 2 )—C(O)—, R 15 —C(S)—O—, R 15 —O—C(S)—, R 15 —C(S)—S—, R 15 —S—C(S)—, R 15 —C(S)—N(R 2 )—, R 15 —N(R 2 )—C(S)—, R 15 —O—C(O)—O—, R 15 —O—C(O)—S—, R 15 —S—C(O)—O—, R 15 —O—C(O)—N(R 2 )—, R 15 —N(R 2 )—C(O)—O—, R 15 —O—C(S)—O—, R 15 —O—C(S)—S—, R 15 —S—C(S)—O—, R 15 —O—C(S)—N(R 2 )—, R 15 —N(R 2 )—C(S)—O—, R 15 —S—C(O)—S—, R 15 —S—C(O)—N(R 2 )—, R 15 —N(R 2 )—C(O)—S—, R 15 —S—C(S)—S—, R 15 —N(R 2 )—C(O)—N(R 2 )—, R 15 —N(R 2 )—C(S)—N(R 2 )—, R 15 —N(R 2 )—C(S)—S—, R 15 —S—C(S)—N(R 2 )—, R 15 —NH—C(N(R 2 ))—NH—, R 15 —S(O) 0-2 —N(R 2 )—, R 15 —N(R 2 )—S(O) 0-2 — and R 15 —N(R 2 )—S(O) 0-2 —N(R 2 )—,

9. The compound claim 1 , wherein X is

wherein

n 4 =0 or 2-4 and

Z 4 is selected from the group consisting of R 15 —, R 15 —C(O)—, R 13 —C(S)—, R 15 —N(R 2 )—, R 15 —O—, R 15 —S—, R 15 —S(O) 1-2 , R 15 —C(O)—O—, R 15 —O—C(O)—, R 15 —C(O)—S—, R 15 —S—C(O)—, R 15 —C(O)—N(R 2 )—, R 15 —N(R 2 )—C(O)—, R 15 —C(S)—O—, R 15 —O—C(S)—, R 15 —C(S)—S—, R 15 —S—C(S)—, R 15 —C(S)—N(R 2 )—, R 15 —N(R 2 )—C(S)—, R 15 —O—C(O)—O—, R 15 —O—C(O)—S—, R 15 —S—C(O)—O—, R 15 —O—C(O)—N(R 2 )—, R 15 —N(R 2 )—C(O)—O—, R 15 —O—C(S)—O—, R 15 —O—C(S)—S—, R 15 —S—C(S)—O—, R 15 —O—C(S)—N(R 2 )—, R 15 —N(R 2 )—C(S)—O—, R 15 —S—C(O)—S—, R 15 —S—C(O)—N(R 2 )—, R 15 —N(R 2 )—C(O)—S—, R 15 —S—C(S)—S—, R 15 —N(R 2 )—C(O)—N(R 2 )—, R 15 —N(R 2 )—C(S)—N(R 2 )—, R 15 —N(R 2 )—C(S)—S—, R 15 —S—C(S)—N(R 2 )—, R 15 —NH—C(N(R 2 ))—NH—, R 15 —S(O) 0-2 —N(R 2 )—, R 15 —N(R)—S(O) 0-2 — and R 15 —N(R 2 )—S(O) 0-2 —N(R 2 )—,

10. The compound according to claim 1 , wherein X is

wherein

n 5 =1-4,

n 6 =1-4,

n 7 =1-4,

Z 5 is selected from the group consisting of R 15 —, R 15 —C(O)—, R 13 —C(S)—, R 15 —N(R 2 )—, R 15 —O—, R 15 —S—, R 15 —S(O) 1-2 , R 15 —C(O)—O—, R 15 —O—C(O)—, R 15 —C(O)—S—, R 15 —S—C(O)—, R 15 —C(O)—N(R 2 )—, R 15 —N(R 2 )—C(O)—, R 15 —C(S)—O—, R 15 —O—C(S)—, R 15 —C(S)—S—, R 15 —S—C(S)—, R 15 —C(S)—N(R 2 )—, R 15 —N(R 2 )—C(S)—, R 15 —O—C(O)—O—, R 15 —O—C(O)—S—, R 15 —S—C(O)—O—, R 15 —O—C(O)—N(R 2 )—, R 15 —N(R 2 )—C(O)—O—, R 15 —O—C(S)—O—, R 15 —O—C(S)—S—, R 15 —S—C(S)—O—, R 15 —O—C(S)—N(R 2 )—, R 15 —N(R 2 )—C(S)—O—, R 15 —S—C(O)—S—, R 15 —S—C(O)—N(R 2 )—, R 15 —N(R 2 )—C(O)—S—, R 15 —S—C(S)—S—, R 15 —N(R 2 )—C(O)—N(R 2 )—, R 15 —N(R 2 )—C(S)—N(R 2 )—, R 15 —N(R 2 )—C(S)—S—, R 15 —S—C(S)—N(R 2 )—, R 15 —NH—C(N(R 2 ))—NH—, R 15 —S(O) 0-2 —N(R 2 )—, R 15 —N(R)—S(O) 0-2 — and R 15 —N(R 2 )—S(O) 0-2 —N(R 2 )—;

Z 6 is selected from the group consisting of R 15 —, R 15 —C(O)—, R 13 —C(S)—, R 15 —N(R 2 )—, R 15 —O—, R 15 —S—, R 15 —S(O) 1-2 , R 15 —C(O)—O—, R 15 —O—C(O)—, R 15 —C(O)—S—, R 15 —S—C(O)—, R 15 —C(O)—N(R 2 )—, R 15 —N(R 2 )—C(O)—, R 15 —C(S)—O—, R 15 —O—C(S)—, R 15 —C(S)—S—, R 15 —S—C(S)—, R 15 —C(S)—N(R 2 )—, R 15 —N(R 2 )—C(S)—, R 15 —O—C(O)—O—, R 15 —O—C(O)—S—, R 15 —S—C(O)—O—, R 15 —O—C(O)—N(R 2 )—, R 15 —N(R 2 )—C(O)—O—, R 15 —O—C(S)—O—, R 15 —O—C(S)—S—, R 15 —S—C(S)—O—, R 15 —O—C(S)—N(R 2 )—, R 15 —N(R 2 )—C(S)—O—, R 15 —S—C(O)—S—, R 15 —S—C(O)—N(R 2 )—, R 15 —N(R 2 )—C(O)—S—, R 15 —S—C(S)—S—, R 15 —N(R 2 )—C(O)—N(R 2 )—, R 15 —N(R 2 )—C(S)—N(R 2 )—, R 15 —N(R 2 )—C(S)—S—, R 15 —S—C(S)—N(R 2 )—, R 15 —NH—C(N(R 2 ))—NH—, R 15 —S(O) 0-2 —N(R 2 )—, R 15 —N(R)—S(O) 0-2 — and R 15 —N(R 2 )—S(O) 0-2 —N(R 2 )—; and

Z 7 is selected from the group consisting of R 15 —, R 15 —C(O)—, R 13 —C(S)—, R 15 —N(R 2 )—, R 15 —O—, R 15 —S—, R 15 —S(O) 1-2 , R 15 —C(O)—O—, R 15 —O—C(O)—, R 15 —C(O)—S—, R 15 —S—C(O)—, R 15 —C(O)—N(R 2 )—, R 15 —N(R 2 )—C(O)—, R 15 —C(S)—O—, R 15 —O—C(S)—, R 15 —C(S)—S—, R 15 —S—C(S)—, R 15 —C(S)—N(R 2 )—, R 15 —N(R 2 )—C(S)—, R 15 —O—C(O)—O—, R 15 —O—C(O)—S—, R 15 —S—C(O)—O—, R 15 —O—C(O)—N(R 2 )—, R 15 —N(R 2 )—C(O)—O—, R 15 —O—C(S)—O—, R 15 —O—C(S)—S—, R 15 —S—C(S)—O—, R 15 —O—C(S)—N(R 2 )—, R 15 —N(R 2 )—C(S)—O—, R 15 —S—C(O)—S—, R 15 —S—C(O)—N(R 2 )—, R 15 —N(R 2 )—C(O)—S—, R 15 —S—C(S)—S—, R 15 —N(R 2 )—C(O)—N(R 2 )—, R 15 —N(R 2 )—C(S)—N(R 2 )—, R 15 —N(R 2 )—C(S)—S—, R 15 —S—C(S)—N(R 2 )—, R 15 —NH—C(N(R 2 ))—NH—, R 15 —S(O) 0-2 —N(R 2 )—, R 15 —N(R 2 )—S(O) 12 — and R 15 —N(R 2 )—S(O) 0-2 —N(R 2 )—.

11. The compound according to claim 1 , wherein X is

wherein

12. A composition comprising a compound according to claim 1 present in at least about 30% enantiomeric or diastereomeric excess.

13. The composition according to claim 12 wherein the compound is present in at least about 50% enantiomeric or diastereomeric excess.

14. The composition according to claim 12 wherein the compound is present in at least 80% enantiomeric or diastereomeric excess.

15. The composition according to claim 12 wherein the compound is present in at least 90% enantiomeric or diastereomeric excess.

16. A composition comprising a compound according to claim 1 present as a substantially racemic mixture.

17. A pharmaceutical composition comprising a compound according to claim 1 , and a pharmaceutically acceptable, diluent, carrier or excipient.

Assignments (4)

CHANGE OF NAME Recorded Oct 27, 2010

From: METHYLGENE, INC.

To: 92229129 QUEBEC INC.

Reel/Frame 025200/0827 →

MERGER Recorded Oct 27, 2010

From: 7503547 CANADA INC.

To: METHYLGENE, INC.

Reel/Frame 025201/0647 →

CHANGE OF NAME Recorded Oct 19, 2010

From: 922209129 QUEBEC INC., (FORMERLY "METHYLGENE, INC.")

To: 7503547 CANADA, INC.

Reel/Frame 025159/0476 →

ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 7, 2008

From: FRECHETTE, SYLVIE; ISAKOVIC, LUBO; PAQUIN, ISABELLE; ROY, SIMON; MORADEI, OSCAR; VAISBURG, ARKADII

To: METHYLGENE INC.

Reel/Frame 020911/0488 →